https://www.openbell.ai/ 2026-10-15T20:36:18.937Z hourly 1.0 https://www.openbell.ai/support 2026-10-15T20:36:18.937Z monthly 0.7 https://www.openbell.ai/privacy 2026-10-15T20:36:18.937Z monthly 0.5 https://www.openbell.ai/terms 2026-10-15T20:36:18.937Z monthly 0.5 https://www.openbell.ai/feed.json 2026-10-15T20:36:18.937Z hourly 0.8 https://www.openbell.ai/news/XXII:1792096428561 2026-10-15T20:33:48.561Z daily 0.9 https://cdn.brandfetch.io/XXII/w/400/h/400?c=1idopYfmtR7ZKg8QMud 22nd Century Group Reports 161% Increase In Sales In Q3 From Q2 For Combined Same-Store Retail Units Of Pinnacle VLN, Pinnacle Pure 22nd Century Group, Inc. (Nasdaq: XXII) reported a 161% increase in combined same-store retail unit sales of Pinnacle VLN and Pinnacle Pure from Q2 to Q3. This growth was attributed to increased consumer awareness and enhanced marketing efforts. The sales were recorded at a retail partner with approximately 1,500 outlets. https://www.openbell.ai/news/CNXU:1792096395629 2026-10-15T20:33:15.629Z daily 0.9 https://cdn.brandfetch.io/CNXU/w/400/h/400?c=1idopYfmtR7ZKg8QMud Conexeu Sciences Closes ~$5M Private Placement At $3.00/Unit With Warrants At $3.00/Share, Led By Existing Holders Including CEO openbell Financial News https://www.openbell.ai/news/CSWC:1792096351913 2026-10-15T20:32:31.913Z daily 0.9 https://cdn.brandfetch.io/CSWC/w/400/h/400?c=1idopYfmtR7ZKg8QMud Capital Southwest Reports Preliminary Fiscal Q2 2027 Net Investment Income Of $0.56-$0.57/Share, NAV Of $16.62-$16.67/Share openbell Financial News https://www.openbell.ai/news/CTW:1792096261676 2026-10-15T20:31:01.676Z daily 0.9 https://cdn.brandfetch.io/CTW/w/400/h/400?c=1idopYfmtR7ZKg8QMud CTW Cayman FY EPS $0.07 Misses $0.09 Estimate, Sales $82.509M Down From $90.371M YoY CTW Cayman (NASDAQ: CTW) reported quarterly earnings of $0.07 per share, missing the analyst consensus estimate of $0.09 by 22.22%. This represents a 16.67% increase from $0.06 per share in the same period last year. The company reported sales of $82.509 million, an 8.70% decrease from $90.371 million year-over-year. https://www.openbell.ai/news/MGY:1792096101569 2026-10-15T20:28:21.569Z daily 0.9 https://cdn.brandfetch.io/MGY/w/400/h/400?c=1idopYfmtR7ZKg8QMud Scotiabank Initiates Coverage On Magnolia Oil & Gas with Sector Outperform Rating, Announces Price Target of $31 Scotiabank analyst Mark Lear has initiated coverage on Magnolia Oil & Gas (NYSE: MGY) with a Sector Outperform rating. The firm has set a price target of $31 for the company's stock. https://www.openbell.ai/news/HAIN:1792095963098 2026-10-15T20:26:03.098Z daily 0.9 https://cdn.brandfetch.io/HAIN/w/400/h/400?c=1idopYfmtR7ZKg8QMud 'Wellness Company Hain Celestial Said to Eye Potential Bankruptcy' - Bloomberg Exclusive Hain Celestial, a wellness company, is reportedly considering potential bankruptcy as it faces financial difficulties. The company's stock, traded under the ticker HAIN, has been under pressure amid these challenges. Specific financial figures or strategic changes were not detailed in the article. https://www.openbell.ai/news/GPOR:1792095924960 2026-10-15T20:25:24.960Z daily 0.9 https://cdn.brandfetch.io/GPOR/w/400/h/400?c=1idopYfmtR7ZKg8QMud Scotiabank Initiates Coverage On Gulfport Energy with Sector Outperform Rating, Announces Price Target of $217 Scotiabank analyst Mark Lear has initiated coverage on Gulfport Energy (NYSE: GPOR) with a Sector Outperform rating. The analyst has set a price target of $217 for the company's stock. https://www.openbell.ai/news/AR:1792095838723 2026-10-15T20:23:58.723Z daily 0.9 https://cdn.brandfetch.io/AR/w/400/h/400?c=1idopYfmtR7ZKg8QMud Scotiabank Initiates Coverage On Antero Resources with Sector Outperform Rating, Announces Price Target of $46 Scotiabank analyst Mark Lear has initiated coverage on Antero Resources (NYSE: AR) with a Sector Outperform rating. The bank has set a price target of $46 for the company's stock. https://www.openbell.ai/news/FBIN:1792095825991 2026-10-15T20:23:45.991Z daily 0.9 https://cdn.brandfetch.io/FBIN/w/400/h/400?c=1idopYfmtR7ZKg8QMud Fortune Brands Innovations To Sell Fiberon Decking Business To Inteplast For $160M; Expects Additional Impairment Charge Of Up To $205M Fortune Brands Innovations, Inc. has agreed to sell its Fiberon decking business to Inteplast Group Corporation for $160 million in cash. Following a recoverability test, the company recorded a long-lived asset impairment of $221.2 million related to Fiberon, which included a reduction in the carrying value of customer relationships and property. Additionally, an expected non-cash impairment charge of $175 million to $205 million is anticipated due to the sale. https://www.openbell.ai/news/DJCO:1792095818668 2026-10-15T20:23:38.668Z daily 0.9 https://cdn.brandfetch.io/DJCO/w/400/h/400?c=1idopYfmtR7ZKg8QMud Daily Journal Acquires Revir Technologies; Financial Terms Undisclosed Daily Journal Corporation (NASDAQ: DJCO) has acquired Revir Technologies, a software company specializing in digital evidence management for law enforcement and public safety agencies. The acquisition, which closed on October 13, 2026, was funded with cash on hand, but financial terms were not disclosed. Revir will operate independently within Daily Journal's new Courts, Justice, and Government Technology division, alongside Journal Technologies, and is not expected to materially impact Daily Journal's financial condition or operations. https://www.openbell.ai/news/CHRD:1792095741590 2026-10-15T20:22:21.590Z daily 0.9 https://cdn.brandfetch.io/CHRD/w/400/h/400?c=1idopYfmtR7ZKg8QMud Scotiabank Initiates Coverage On Chord Energy with Sector Outperform Rating, Announces Price Target of $192 Scotiabank analyst Mark Lear has initiated coverage on Chord Energy (NASDAQ: CHRD) with a Sector Outperform rating. The firm has set a price target of $192 for the stock. https://www.openbell.ai/news/CBAN:1792095456489 2026-10-15T20:17:36.489Z daily 0.9 https://cdn.brandfetch.io/CBAN/w/400/h/400?c=1idopYfmtR7ZKg8QMud Colony Bankcorp And First Reliance Bancshares Jointly Announce Shareholders' Approval For Proposed Business Combination Colony Bankcorp, Inc. (NYSE: CBAN) and First Reliance Bancshares, Inc. (OTCQX: FSRL) have announced that shareholders from both companies have approved the merger, allowing First Reliance to become part of Colony. This strategic move is expected to enhance Colony's market position and operational capabilities. https://www.openbell.ai/news/FANG:1792095454838 2026-10-15T20:17:34.838Z daily 0.9 https://cdn.brandfetch.io/FANG/w/400/h/400?c=1idopYfmtR7ZKg8QMud Scotiabank Initiates Coverage On Diamondback Energy with Sector Outperform Rating, Announces Price Target of $250 Scotiabank analyst Mark Lear has initiated coverage on Diamondback Energy (NASDAQ: FANG) with a Sector Outperform rating. The firm has set a price target of $250 for the company's stock. https://www.openbell.ai/news/VRNS:1792095391125 2026-10-15T20:16:31.125Z daily 0.9 https://cdn.brandfetch.io/VRNS/w/400/h/400?c=1idopYfmtR7ZKg8QMud Varonis Systems Agrees To Be Acquired By Thoma Bravo's Proofpoint For ~$6.3B In Cash Varonis Systems, Inc. has entered into a definitive agreement to be acquired by Proofpoint, Inc., a Thoma Bravo portfolio company, for approximately $6.3 billion in cash. This acquisition marks a significant move in the data and AI security sector, as Varonis is recognized as a leader in this field. https://www.openbell.ai/news/SNTI:1792095348516 2026-10-15T20:15:48.516Z daily 0.9 https://cdn.brandfetch.io/SNTI/w/400/h/400?c=1idopYfmtR7ZKg8QMud Senti Biosciences shares are trading higher after the company announced it received stockholders' approval for its merger with ST NewCo. openbell Financial News https://www.openbell.ai/news/SRTA:1792095317709 2026-10-15T20:15:17.709Z daily 0.9 https://cdn.brandfetch.io/SRTA/w/400/h/400?c=1idopYfmtR7ZKg8QMud Third Point Says Acquired Strata Critical Medical's Securities For Investment Purposes And Believe That Common Stock Is "Undervalued" openbell Financial News https://www.openbell.ai/news/SRTA:1792095260240 2026-10-15T20:14:20.240Z daily 0.9 https://cdn.brandfetch.io/SRTA/w/400/h/400?c=1idopYfmtR7ZKg8QMud Third Point's Daniel Loeb Urges Strata Critical Medical To Explore Strategic Alternatives Including Potential Sale Daniel Loeb of Third Point has urged Strata Critical Medical (SRTA) to explore strategic alternatives, including a potential sale, due to concerns over the company's overhead not being supported by its current scale. The Reporting Persons believe the company's common stock is undervalued and plan to communicate with management and other shareholders regarding operational and governance matters. They may also consider purchasing additional shares or selling their current holdings based on future evaluations of the company's financial position and market conditions. https://www.openbell.ai/news/BTCUSD:1792095204880 2026-10-15T20:13:24.880Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/15/Bitcoin-Btc-Virtual-Cryptocurrency-In-Fr.jpg?width=250&height=187 Bitcoin Wins Whether AI Booms or Busts, Bitwise Exec Says: ‘All Roads Lead to Bitcoin’ Bitwise executive Matt Hougan asserts that regardless of the trajectory of the AI economy—whether it experiences a boom, bust, or remains stable—Bitcoin (CRYPTO: BTC) is positioned to rise. He outlines three potential scenarios: a superabundance driven by AI leading to increased demand for scarce assets like Bitcoin, a bubble burst resulting in initial declines but ultimately benefiting Bitcoin through government intervention, and a stable growth scenario where Bitcoin continues to attract investment. Hougan emphasizes that nearly all macroeconomic conditions favor Bitcoin's growth as a store of value. https://www.openbell.ai/news/JBHT:1792095172414 2026-10-15T20:12:52.414Z daily 0.9 https://cdn.brandfetch.io/JBHT/w/400/h/400?c=1idopYfmtR7ZKg8QMud J.B. Hunt Transport Services shares are trading lower after the company reported worse-than-expected Q3 EPS results. openbell Financial News https://www.openbell.ai/news/BZH:1792095070146 2026-10-15T20:11:10.146Z daily 0.9 https://cdn.brandfetch.io/BZH/w/400/h/400?c=1idopYfmtR7ZKg8QMud Beazer Homes Says Stockholders Approve Merger With Dream Finders Homes; Expects To Announce Completion Within Coming Days Beazer Homes announced that its stockholders have approved the merger with Dream Finders Homes. The company expects to announce the completion of the merger within the coming days. This strategic move is anticipated to impact the market positively as Beazer Homes continues to expand its operations. https://www.openbell.ai/news/INDB:1792095065890 2026-10-15T20:11:05.890Z daily 0.9 https://cdn.brandfetch.io/INDB/w/400/h/400?c=1idopYfmtR7ZKg8QMud Independent Bank Q3 Adj. EPS $1.90 Beats $1.84 Estimate, Sales $261.948M Beat $261.040M Estimate Independent Bank (NASDAQ: INDB) reported Q3 adjusted earnings per share of $1.90, surpassing the analyst estimate of $1.84 by 3.26%, and marking a 22.58% increase from $1.55 per share in the same quarter last year. The company's quarterly sales reached $261.948 million, exceeding the expected $261.040 million by 0.35%, and reflecting a 7.47% increase from $243.742 million in the prior year. https://www.openbell.ai/news/LCNB:1792095030448 2026-10-15T20:10:30.448Z daily 0.9 https://cdn.brandfetch.io/LCNB/w/400/h/400?c=1idopYfmtR7ZKg8QMud LCNB Q3 EPS $0.51 Beats $0.47 Estimate, Sales $25.020M Beat $24.500M Estimate openbell Financial News https://www.openbell.ai/news/NYXH:1792094905728 2026-10-15T20:08:25.728Z daily 0.9 https://cdn.brandfetch.io/NYXH/w/400/h/400?c=1idopYfmtR7ZKg8QMud Nyxoah Submits FDA Application To Expand Genio Indication To Complete Concentric Collapse Patients; Pivotal Data Show 74.3% Median Reduction In Apnea Events openbell Financial News https://www.openbell.ai/news/MGNX:1792094807378 2026-10-15T20:06:47.378Z daily 0.9 https://cdn.brandfetch.io/MGNX/w/400/h/400?c=1idopYfmtR7ZKg8QMud MacroGenics Doses First Patient In Phase 1 Study Of MGC030, Antibody-Drug Conjugate Directed Against Undisclosed Target, In Patients With Advanced Solid Tumors MacroGenics, Inc. (NASDAQ: MGNX) has announced the dosing of the first patient in a Phase 1 study of MGC030, a first-in-class antibody-drug conjugate targeting an undisclosed antigen in patients with advanced solid tumors. The study is designed to assess the safety, tolerability, pharmacokinetics, and preliminary antitumor activity of MGC030, with up to 54 participants expected in the dose escalation phase, which may expand further at selected dose levels. https://www.openbell.ai/news/CRWV:1792094738759 2026-10-15T20:05:38.759Z daily 0.9 https://cdn.brandfetch.io/CRWV/w/400/h/400?c=1idopYfmtR7ZKg8QMud CoreWeave’s Bonds Hit 15% Yield: This Analyst Still Sees 105% Upside For The Stock CoreWeave Inc. (NASDAQ: CRWV) has seen its bond yields rise to over 15%, indicating financial strain, while its stock price has fallen approximately 16% recently, sitting 65% below its May 2025 peak. Despite this, Bank of America maintains a Buy rating with a price target of $140, suggesting a potential upside of 105%. The bank has raised its revenue growth forecasts to 105% for 2027 and 63% for 2028, driven by increased capacity and pricing. However, concerns remain regarding CoreWeave's projected negative free cash flow and significant cash needs for upcoming years. https://www.openbell.ai/news/AVXL:1792094668092 2026-10-15T20:04:28.092Z daily 0.9 https://cdn.brandfetch.io/AVXL/w/400/h/400?c=1idopYfmtR7ZKg8QMud Anavex Life Sciences Receives FDA Clearance to Proceed Ahead With Its Planned Clinical Trial Under Its Investigational New Drug Application For ANAVEX 2-73 For Fragile X Syndrome Anavex Life Sciences Corp. has received FDA clearance to proceed with its clinical trial for ANAVEX 2-73 (blarcamesine) targeting Fragile X syndrome, a genetic condition with no FDA-approved treatments. The Investigational New Drug Application (IND) is now open, allowing for clinical investigation in the U.S. Blarcamesine has previously been granted Orphan Drug Designation by the FDA for this condition. https://www.openbell.ai/news/IBKR:1792094636989 2026-10-15T20:03:56.989Z daily 0.9 https://cdn.brandfetch.io/IBKR/w/400/h/400?c=1idopYfmtR7ZKg8QMud Interactive Brokers Raises Quarterly Dividend From $0.0875 To $0.15/Share openbell Financial News https://www.openbell.ai/news/CTNT:1792094564949 2026-10-15T20:02:44.949Z daily 0.9 https://cdn.brandfetch.io/CTNT/w/400/h/400?c=1idopYfmtR7ZKg8QMud Cheetah Net Says It Plans To Oppose Takeover Time 2026’s Consent Solicitation Seeking To Replace Its Board openbell Financial News https://www.openbell.ai/news/AVXL:1792094558611 2026-10-15T20:02:38.611Z daily 0.9 https://cdn.brandfetch.io/AVXL/w/400/h/400?c=1idopYfmtR7ZKg8QMud Anavex Life Sciences shares are trading higher after the company announced it has received notification from the FDA that the company may proceed with its planned clinical study under its Investigational New Drug Application for ANAVEX 2-73 for Fragile X syndrome. openbell Financial News https://www.openbell.ai/news/AVXL:1792094533002 2026-10-15T20:02:13.002Z daily 0.9 https://cdn.brandfetch.io/AVXL/w/400/h/400?c=1idopYfmtR7ZKg8QMud Anavex Life Sciences Receives FDA Clearance to Proceed Ahead With Its Planned Clinical Trial Under Its Investigational New Drug Application For ANAVEX For Fragile X Syndrome Anavex Life Sciences Corp. has received FDA clearance to proceed with its clinical trial for ANAVEX®2-73 (blarcamesine) under its Investigational New Drug Application for Fragile X syndrome, a genetic condition with no FDA-approved treatment. The IND is now open, allowing for clinical investigation in the U.S. Blarcamesine has also received Orphan Drug Designation from the FDA for this condition. https://www.openbell.ai/news/IRD:1792094526003 2026-10-15T20:02:06.003Z daily 0.9 https://cdn.brandfetch.io/IRD/w/400/h/400?c=1idopYfmtR7ZKg8QMud Opus Genetics Presents Clinical Findings From OPGx-BEST1 And OPGx-LCA5 Gene Therapy Programs At Retina In Rio 2026; Phase 3 Clinical Trial Dosing For OPGx-LCA5 Expected In Q4 Of 2026 Opus Genetics, Inc. (NASDAQ: IRD) presented clinical findings from its OPGx-BEST1 and OPGx-LCA5 gene therapy programs at Retina in Rio 2026. In the Phase 1/2 trial of OPGx-BEST1, 75% of evaluable participants showed improved retinal sensitivity, while the OPGx-LCA5 trial demonstrated sustained improvements in visual acuity and light sensitivity in adults over 24 months and in pediatric participants over six months. The company plans to begin Phase 3 clinical trial dosing for OPGx-LCA5 in Q4 of 2026. https://www.openbell.ai/news/AVXL:1792094497257 2026-10-15T20:01:37.257Z daily 0.9 https://cdn.brandfetch.io/AVXL/w/400/h/400?c=1idopYfmtR7ZKg8QMud Anavex Life Sciences Receives FDA Clearance to Proceed Ahead With Its Planned Clinical Trial Under Its Investigational New Drug Application For ANAVEX For Fragile X Syndrome Anavex Life Sciences Corp. has received FDA clearance to proceed with its clinical trial for ANAVEX®2-73 (blarcamesine) targeting Fragile X syndrome, a genetic condition with no existing FDA-approved treatments. The Investigational New Drug Application (IND) is now open, allowing for clinical investigation in the U.S. Blarcamesine has previously been granted Orphan Drug Designation by the FDA for this indication. https://www.openbell.ai/news/MDXH:1792094484259 2026-10-15T20:01:24.259Z daily 0.9 https://cdn.brandfetch.io/MDXH/w/400/h/400?c=1idopYfmtR7ZKg8QMud MDxHealth Suspends FY2026 Revenue Guidance Of $110M-$115M; Reports Preliminary Q3 Revenue Of About $22.7M vs. $22.7M Year Ago openbell Financial News https://www.openbell.ai/news/GRID:1792094303922 2026-10-15T19:58:23.922Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/15/High-Power-Electricity-grid.jpg?width=250&height=187 Trump’s Power Grid Emergency Puts This AI Infrastructure ETFs in the Spotlight The Department of Energy issued an emergency order for additional power generation across the PJM Interconnection from October 13 to 16 due to unusual heat and rising demand, affecting over 67 million people. This situation highlights the growing electricity needs driven by AI infrastructure, potentially benefiting ETFs like the First Trust NASDAQ Clean Edge Smart Grid Infrastructure ETF (NASDAQ: GRID), which includes major holdings such as Quanta Services Inc. and Johnson Controls International PLC. Additionally, PJM proposed a $12.2 billion grid upgrade plan to address rising demand and congestion, further emphasizing the long-term infrastructure challenges in the power sector. https://www.openbell.ai/news/CRGY:1792094291312 2026-10-15T19:58:11.312Z daily 0.9 https://cdn.brandfetch.io/CRGY/w/400/h/400?c=1idopYfmtR7ZKg8QMud Scotiabank Initiates Coverage On Crescent Energy with Sector Outperform Rating, Announces Price Target of $18 Scotiabank analyst Mark Lear has initiated coverage on Crescent Energy (NYSE: CRGY) with a Sector Outperform rating. The bank has set a price target of $18 for the company's stock. https://www.openbell.ai/news/COHR:1792094091221 2026-10-15T19:54:51.221Z daily 0.9 https://cdn.brandfetch.io/COHR/w/400/h/400?c=1idopYfmtR7ZKg8QMud Coherent shares are trading lower after B. Riley Securities lowered its price target on the stock from $345 to $297. openbell Financial News https://www.openbell.ai/news/MSFT:1792094035493 2026-10-15T19:53:55.493Z daily 0.9 https://cdn.brandfetch.io/MSFT/w/400/h/400?c=1idopYfmtR7ZKg8QMud Citigroup Maintains Buy on Microsoft, Raises Price Target to $636 Citigroup analyst Tyler Radke has maintained a 'Buy' rating on Microsoft (NASDAQ: MSFT) and raised the price target from $600 to $636. This adjustment reflects a positive outlook for the company's performance in the market. https://www.openbell.ai/news/META:1792093772847 2026-10-15T19:49:32.847Z daily 0.9 https://cdn.brandfetch.io/META/w/400/h/400?c=1idopYfmtR7ZKg8QMud Citigroup Maintains Buy on Meta Platforms, Raises Price Target to $895 Citigroup analyst Ronald Josey has maintained a Buy rating on Meta Platforms (NASDAQ: META) and raised the price target from $800 to $895. This adjustment reflects an optimistic outlook on the company's performance. https://www.openbell.ai/news/LRCX:1792093426555 2026-10-15T19:43:46.555Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/15/LAM-Research.jpg?width=250&height=187 Lam Research Stock Hits Longest Losing Streak Ever: Are There Buyers Around? Lam Research Corp. (NASDAQ: LRCX) has experienced its longest losing streak in history, closing lower for nine consecutive sessions and dropping 21.7% since October 5. Despite this decline, analysts remain optimistic, with 21 out of 22 rating the stock a Buy and an average price target of $346, indicating a potential upside of 26.3% from its current price of $274.12. The company is set to report its September-quarter results on October 21, with projected revenues of $8.1 billion, significantly higher than the previous quarter's $6.72 billion. https://www.openbell.ai/news/CAKE:1792093355324 2026-10-15T19:42:35.324Z daily 0.9 https://cdn.brandfetch.io/CAKE/w/400/h/400?c=1idopYfmtR7ZKg8QMud Citigroup Maintains Buy on The Cheesecake Factory, Raises Price Target to $128 Citigroup analyst Jon Tower has reiterated a Buy rating on The Cheesecake Factory (NASDAQ: CAKE) and increased the price target from $104 to $128. This adjustment reflects a positive outlook for the company's stock performance. https://www.openbell.ai/news/CLH:1792092846936 2026-10-15T19:34:06.936Z daily 0.9 https://cdn.brandfetch.io/CLH/w/400/h/400?c=1idopYfmtR7ZKg8QMud Citigroup Maintains Buy on Clean Harbors, Raises Price Target to $378 Citigroup analyst Bryan Burgmeier has reaffirmed a Buy rating on Clean Harbors (NYSE: CLH) and increased the price target from $376 to $378. This adjustment reflects a positive outlook for the company's stock performance. https://www.openbell.ai/news/NOG:1792092269596 2026-10-15T19:24:29.596Z daily 0.9 https://cdn.brandfetch.io/NOG/w/400/h/400?c=1idopYfmtR7ZKg8QMud Citigroup Maintains Buy on Northern Oil & Gas, Raises Price Target to $32 Citigroup analyst Paul Diamond has reiterated a 'Buy' rating on Northern Oil & Gas (NYSE: NOG) and increased the price target from $28 to $32. This adjustment reflects a positive outlook for the company's stock performance. https://www.openbell.ai/news/TALO:1792091982574 2026-10-15T19:19:42.574Z daily 0.9 https://cdn.brandfetch.io/TALO/w/400/h/400?c=1idopYfmtR7ZKg8QMud Citigroup Maintains Buy on Talos Energy, Raises Price Target to $21 Citigroup analyst Paul Diamond has maintained a Buy rating on Talos Energy (NYSE: TALO) and increased the price target from $18 to $21. This adjustment reflects a positive outlook on the company's performance. https://www.openbell.ai/news/XRPUSD:1792091108536 2026-10-15T19:05:08.536Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/15/Digital-Art-Xrp-Logo-Symbol--Ripple-Cryp.jpg?width=250&height=187 Ripple Scores Another Banking Deal as XRP Flashes Buy Signals Cross River Bank is integrating Ripple's RLUSD stablecoin into its core banking system, enabling fintechs to access RLUSD payments via a single API for real-time and cross-border transactions. The RLUSD has a market cap exceeding $2.5 billion and has processed over $1.3 trillion in total value. Meanwhile, XRP has shown buy signals after recovering to $1.33, with analysts suggesting a potential rebound towards $1.40 if buying momentum continues. https://www.openbell.ai/news/FER:1792091098695 2026-10-15T19:04:58.695Z daily 0.9 https://cdn.brandfetch.io/FER/w/400/h/400?c=1idopYfmtR7ZKg8QMud Ferrovial-Led Consortium Selected For $8.9B I-285 East Express Lanes Project In Atlanta, GA Ferrovial, through its consortium Top End Mobility Group, has been awarded the I-285 East Express Lanes project in Atlanta, Georgia, with a construction value of $8.9 billion. This project aims to improve mobility and connectivity in the metropolitan area and is part of a public-private partnership with the Georgia Department of Transportation and the State Road and Tollway Authority. https://www.openbell.ai/news/ZS:1792090826594 2026-10-15T19:00:26.594Z daily 0.9 https://cdn.brandfetch.io/ZS/w/400/h/400?c=1idopYfmtR7ZKg8QMud Citigroup Maintains Buy on Zscaler, Raises Price Target to $260 Citigroup analyst Fatima Boolani has reaffirmed a 'Buy' rating on Zscaler (NASDAQ: ZS) and increased the price target from $245 to $260. This adjustment reflects Citigroup's positive outlook on the company's performance. https://www.openbell.ai/news/PAYC:1792090741105 2026-10-15T18:59:01.105Z daily 0.9 https://cdn.brandfetch.io/PAYC/w/400/h/400?c=1idopYfmtR7ZKg8QMud Watching Paycom Software; Hearing Investor Business Daily SwingTrader Buys Stock openbell Financial News https://www.openbell.ai/news/PANW:1792090582754 2026-10-15T18:56:22.754Z daily 0.9 https://cdn.brandfetch.io/PANW/w/400/h/400?c=1idopYfmtR7ZKg8QMud Citigroup Maintains Buy on Palo Alto Networks, Raises Price Target to $440 Citigroup analyst Fatima Boolani has maintained a 'Buy' rating on Palo Alto Networks (NASDAQ: PANW) and raised the price target from $410 to $440. This adjustment reflects a positive outlook for the company in the cybersecurity sector. https://www.openbell.ai/news/CAVA:1792090483560 2026-10-15T18:54:43.560Z daily 0.9 https://cdn.brandfetch.io/CAVA/w/400/h/400?c=1idopYfmtR7ZKg8QMud Shares of restaurant and food delivery companies are trading higher as retreating bond yields and investors trimming exposure to AI-exposed tech names help drive a rebound following September's inflation-driven declines. openbell Financial News https://www.openbell.ai/news/INTC:1792090439844 2026-10-15T18:53:59.844Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/15/image.png?width=250&height=187 Intel Shares Rise Over 3% After Key Trading Signal Intel Corporation (NASDAQ: INTC) saw its shares rise over 3% following a Power Inflow alert, a bullish trading signal, on October 15 at 10:29 AM EST, when the stock was priced at $91.75. The alert indicated a significant shift in buying interest from both retail and institutional traders, leading to an intraday high of $95.08 by 1:00 PM EST. This signal, developed by TradePulse, highlights moments of increased buying activity, suggesting potential bullish price movement.